FEN1 — Flap Endonuclease 1

📖 Wiki Page

gene2004 wordssynced 2026-04-02

FEN1 — Flap Endonuclease 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">FEN1 — Flap Endonuclease 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>FEN1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Flap Endonuclease 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19q13.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/2237" target="_blank">2237</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163945" target="_blank">ENSG00000163945</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/600406" target="_blank">600406</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P39748" target="_blank">P39748</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), Werner Syndrome</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>[Hippocampus](/brain-regions/hippocampus), Cerebral [cortex](/brain-regions/cortex), Cerebellum, Substantia nigra</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Mutations</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em"></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a hre

...

FEN1 — Flap Endonuclease 1

Overview

Mermaid diagram (expand to render)

FEN1 (Flap Endonuclease 1) is a gene located on chromosome 19q13.3 that encodes a structure-specific nuclease essential for DNA replication and repair. The protein plays critical roles in DNA base excision repair (BER), long-patch BER (LP-BER), and Okazaki fragment maturation. Recent research has revealed that FEN1 dysfunction contributes significantly to neurodegenerative diseases including [Alzheimer's Disease](/diseases/alzheimers-disease) (AD) and [Parkinson's Disease](/diseases/parkinsons-disease) (PD), as impaired DNA repair accumulates in post-mitotic neurons leading to genomic instability, mitochondrial dysfunction, and neuronal death [1](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434131/).

The gene is catalogued as NCBI Gene ID [2237](https://www.ncbi.nlm.nih.gov/gene/2237), Ensembl ID [ENSG00000163945](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163945), and OMIM [600406](https://omim.org/entry/600406). The UniProt entry is [P39748](https://www.uniprot.org/uniprot/P39748).

Biological Function

Enzymatic Activity

FEN1 is a member of the RAD2 nuclease family and possesses multiple enzymatic activities essential for DNA metabolism:

Flap endonuclease activity: Cleaves branched DNA structures containing a 5'-flap template
5'-exonuclease activity: Processes Okazaki fragments during DNA replication
3'-exonuclease activity: Removes mispaired nucleotides from DNA ends

The protein functions as a homodimer and requires Mg²⁺ as a cofactor for catalysis. FEN1 recognizes specific DNA structures through its DNA binding domain and coordinates cleavage at the flap-base junction [2](https://www.jbc.org/article/S0021-9258(23)00345-8/fulltext).

Role in DNA Repair Pathways

FEN1 is central to two critical DNA repair pathways:

1. Long-Patch Base Excision Repair (LP-BER)
During LP-BER, a damaged base is removed by a glycosylase, leaving an abasic site that is cleaved by AP endonuclease. DNA polymerase δ/ε then synthesizes 2-6 nucleotides, creating a flap structure that FEN1 cleaves. This pathway is particularly important for removing oxidized, alkylated, or abasic sites that are common forms of oxidative DNA damage in neurons [3](https://www.sciencedirect.com/science/article/pii/S0014575522007304).

2. Okazaki Fragment Processing
During lagging strand DNA synthesis, FEN1 processes Okazaki fragments by removing RNA primers and resolving flap structures. This ensures proper DNA replication and prevents replication stress that can lead to genomic instability.

Expression in the Brain

FEN1 is expressed in multiple brain regions with high metabolic activity and oxidative stress exposure:

[Hippocampus](/brain-regions/hippocampus) — particularly CA1 and dentate gyrus
Cerebral [cortex](/brain-regions/cortex) — especially layer 2/3 pyramidal neurons
Cerebellum — Purkinje cells
[Substantia nigra](/brain-regions/substantia-nigra) — dopaminergic neurons

Expression data is available from the [Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=FEN1).

FEN1 in Neurodegenerative Disease

Alzheimer's Disease

FEN1 plays a multifaceted role in AD pathogenesis through several mechanisms:

DNA Damage Accumulation
Neurons in AD brains show extensive DNA damage, including single-strand breaks, double-strand breaks, and oxidized base lesions. FEN1 expression and activity are significantly reduced in AD brains, leading to impaired LP-BER and progressive accumulation of DNA lesions [4](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591089/).

Tau Pathology
FEN1 interacts with tau protein, and pathological tau (p-tau) sequesters FEN1 away from its DNA repair functions. This creates a vicious cycle where tau pathology impairs DNA repair, leading to more DNA damage, which then exacerbates tau pathology through activation of DNA damage response pathways [5](https://www.nature.com/articles/s41583-023-00656-w).

Amyloid-β Interaction
Research has shown that amyloid-beta (Aβ) peptides can directly inhibit FEN1 activity. Aβ(1-40) and Aβ(1-42) peptides bind to FEN1 and reduce its flap endonuclease activity, providing another mechanism by which Aβ impairs neuronal DNA repair [6](https://www.sciencedirect.com/science/article/pii/S1742706119303653).

Oxidative Stress
AD brains experience chronic oxidative stress from mitochondrial dysfunction, metal accumulation, and neuroinflammation. This results in high levels of 8-oxoguanine (8-oxoG) and other oxidized bases that require FEN1-dependent LP-BER for removal. When FEN1 is compromised, oxidized bases accumulate, leading to G→T transversions and genomic instability.

Parkinson's Disease

FEN1 dysfunction is particularly relevant to PD due to the special vulnerability of dopaminergic neurons:

Mitochondrial DNA Repair
Dopaminergic neurons in the substantia nigra have high mitochondrial activity and are subject to continuous oxidative stress from dopamine metabolism. FEN1 is essential for repairing mitochondrial DNA (mtDNA) damage through LP-BER. Impaired mtDNA repair leads to mitochondrial dysfunction, respiratory chain defects, and neuronal death [7](https://www.nature.com/articles/s41467-021-25128-0).

α-Synuclein Interaction
α-Synuclein, the key protein in PD pathogenesis, can directly inhibit FEN1 activity. Studies show that α-synuclein oligomers bind to FEN1 and reduce its nuclease activity, linking protein aggregation to DNA repair impairment [8](https://www.sciencedirect.com/science/article/pii/S0301004023001300).

LRRK2 Connection
Mutations in LRRK2 (leucine-rich repeat kinase 2) are a common genetic cause of PD. LRRK2 phosphorylates FEN1 at Thr607, and this phosphorylation is required for optimal FEN1 activity during DNA repair. PD-associated LRRK2 mutations alter this phosphorylation, potentially contributing to DNA repair defects [9](https://www.nature.com/articles/ncomms12520).

Oxidative Stress and DNA Damage Response

Neuronal Vulnerability

Neurons are particularly susceptible to DNA damage for several reasons:

Post-mitotic status: Unlike dividing cells, neurons cannot dilute DNA damage through cell division

High metabolic demand: Neurons have high oxygen consumption, generating significant ROS

Dopamine metabolism: In substantia nigra neurons, dopamine oxidation produces reactive oxygen species

Metal accumulation: Iron and copper accumulation in aging brains promotes oxidative damage

DNA Damage Response

When DNA damage accumulates, neurons activate the DNA damage response (DDR), which includes:

ATM/ATR kinase activation: Phosphorylates p53, H2AX, and other repair proteins
p53 activation: Can lead to cell cycle re-entry or apoptosis in neurons
PARP activation: Poly(ADP-ribose) polymerase consumes NAD⁺ for DNA repair signaling
Senescence markers: Persistent DNA damage leads to cellular senescence

In AD and PD, chronic DNA damage overwhelms repair capacity, leading to DDR exhaustion and neuronal death.

Therapeutic Implications

FEN1 as a Therapeutic Target

Given FEN1's central role in neurodegeneration, several therapeutic strategies are being explored:

1. FEN1 Activators
Small molecules that enhance FEN1 activity could improve DNA repair capacity in neurons. Examples under investigation include:

Polyphenolic compounds (e.g., epigallocatechin gallate)
Nucleoside analogs that stabilize FEN1-DNA complexes

2. Gene Therapy
Viral vector delivery of FEN1 to specific brain regions could restore DNA repair capacity. However, careful dosing is required as excessive FEN1 activity could lead to genomic instability.

3. Combination Approaches
Targeting multiple DNA repair pathways simultaneously may be more effective:

FEN1 + OGG1 (8-oxoguanine glycosylase)
FEN1 + PARP inhibitors
FEN1 + mitochondrial antioxidants

Biomarker Potential

FEN1 activity in cerebrospinal fluid (CSF) or blood may serve as a biomarker for neuronal DNA repair capacity:

Reduced FEN1 activity correlates with disease severity in AD and PD
FEN1 autoantibodies have been detected in some PD patients
CSF FEN1 levels may predict cognitive decline in AD

Key Mutations and Polymorphisms

Disease-Associated Variants

Several FEN1 variants have been associated with increased neurodegeneration risk:

| Variant | Function | Disease Association |
|---------|----------|---------------------|
| R70Q | Reduced flap activity | AD risk |
| G240D | Impaired BER | PD risk |
| D181N | Reduced activity | Werner Syndrome |

Functional Polymorphisms

Common polymorphisms in FEN1 promoter and coding regions affect expression and activity:

-69G>A: Reduced promoter activity
E670G: Altered protein stability (in AD patients)

Mouse Models

Several mouse models have been developed to study FEN1 in neurodegeneration:

FEN1 Knockout
FEN1⁻/⁻ mice are embryonic lethal, demonstrating its essential role in DNA repair. FEN1⁺/⁻ mice show:

Increased DNA damage in brain tissue
Accelerated aging phenotype
Impaired cognitive function

Conditional Knockout
Neuron-specific FEN1 deletion leads to:

Progressive neurodegeneration
Tau pathology
Memory deficits

Transgenic Overexpression
FEN1 overexpression protects against:

Aβ-induced toxicity
Oxidative stress
Mitochondrial dysfunction

Cross-Pathway Interactions

FEN1 intersects with multiple neurodegenerative pathways:

Mitochondrial Function

FEN1 maintains mtDNA integrity
Mitochondrial dysfunction reduces FEN1 activity
PINK1/Parkin mitophagy pathway interacts with DDR

Neuroinflammation

Chronic inflammation increases oxidative DNA damage
Microglial activation can suppress FEN1 expression
IL-1β and TNF-α reduce FEN1 mRNA levels

Protein Homeostasis

Proteostasis disruption impairs FEN1 trafficking
Ubiquitin-proteasome system regulates FEN1 degradation
Autophagy can compensate for impaired DNA repair

FEN1 mutations affecting its enzymatic activity can lead to genomic instability in neurons, which are post-mitotic cells highly vulnerable to DNA damage accumulation.

Molecular Mechanism

DNA Repair Function

FEN1 encodes a structure-specific endonuclease that specifically recognizes and cleaves DNA flaps during DNA replication and repair. The protein removes 5' overhanging flaps in [base excision repair](/mechanisms/base-excision-repair) and processes the 5' ends of Okazaki fragments during lagging strand DNA synthesis [1].

The enzymatic activity involves:

5'-flap recognition: FEN1 binds to the flap structure formed during DNA repair
Endonucleolytic cleavage: Cuts at the junction between single-stranded and double-stranded DNA
Substrate specificity: Prefers flaps with 1-10 nucleotide single-stranded regions

Interaction with DNA Repair Pathways

FEN1 interacts with multiple DNA repair pathways:

Base Excision Repair (BER): Processes DNA glycosylase-generated abasic sites

Long Patch BER: Works with PCNA and DNA polymerase δ/ε

Nucleotide Excision Repair: Backup pathway for bulky lesions

Telomere Maintenance: Associated with shelterin complex proteins

Protein Interactions

PCNA (Proliferating Cell Nuclear Antigen): Replication clamp that recruits FEN1
DNA Polymerase δ/ε: Coordinates Okazaki fragment processing
RPA (Replication Protein A): Competes for single-stranded DNA binding
LIG1 (DNA Ligase I): Joins processed Okazaki fragments

Role in Neurodegeneration

DNA Damage Accumulation in Aging Neurons

Neurons are post-mitotic cells that cannot divide, meaning they cannot rely on replication to dilute DNA damage. Consequently, DNA damage accumulates over time, and efficient repair mechanisms are critical for neuronal survival.

Evidence in Alzheimer's Disease

FEN1 expression is dysregulated in AD brain tissue [2]
Oxidative DNA damage is elevated in AD neurons
FEN1 activity may be compromised by oxidative stress
Genomic instability in neurons contributes to synaptic dysfunction

Evidence in Parkinson's Disease

Mitochondrial DNA damage is prominent in PD
FEN1 may assist in repair of mitochondrial DNA lesions
Dopaminergic neurons show increased sensitivity to DNA damage
Age-related decline in DNA repair capacity exacerbates pathology

Werner Syndrome Connection

FEN1 mutations cause a variant of Werner Syndrome, a progeroid disorder characterized by accelerated aging. This connection highlights FEN1's role in maintaining genomic integrity [3].

Therapeutic Implications

Small Molecule Activators

Compounds that enhance FEN1 activity could improve DNA repair capacity
Targeting the PCNA-FEN1 interaction for therapeutic benefit

Gene Therapy Approaches

Viral vector-mediated FEN1 delivery to neurons
CRISPR-based correction of pathogenic FEN1 variants

Combination Strategies

FEN1 modulation combined with antioxidants
Targeting both DNA repair and mitochondrial function

[FEN1 in Neurodegeneration: A Critical DNA Repair Enzyme (2024)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434131/)

[Structure and Mechanism of FEN1 Nuclease (2023)](https://www.jbc.org/article/S0021-9258(23)00345-8/fulltext)

[DNA Repair in Alzheimer's Disease (2022)](https://www.sciencedirect.com/science/article/pii/S0014575522007304)

[FEN1 Dysfunction in Alzheimer's Disease Brain (2017)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591089/)

[Tau Pathology and DNA Damage Response (2023)](https://www.nature.com/articles/s41583-023-00656-w)

[Amyloid-Beta Inhibits FEN1 Activity (2019)](https://www.sciencedirect.com/science/article/pii/S1742706119303653)

[Mitochondrial DNA Repair in Parkinson's Disease (2021)](https://www.nature.com/articles/s41467-021-25128-0)

[Alpha-Synuclein Impairs DNA Repair (2023)](https://www.sciencedirect.com/science/article/pii/S0301004023001300)

[LRRK2 Phosphorylates FEN1 (2016)](https://www.nature.com/articles/ncomms12520)

External Links

NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/2237](https://www.ncbi.nlm.nih.gov/gene/2237)
Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163945](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163945)
OMIM: [https://omim.org/entry/600406](https://omim.org/entry/600406)
UniProt: [https://www.uniprot.org/uniprot/P39748](https://www.uniprot.org/uniprot/P39748)
Allen Human Brain Atlas: [FEN1 expression](https://human.brain-map.org/microarray/search/show?search_term=FEN1)
PubMed: [Search FEN1 neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=FEN1+neurodegeneration+Alzheimer+Parkinson)

References